Skip to main content
BrainCited

Bacopa monnieri for Attention & Focus Difficulties

C Some Evidence Limited evidence from small studies, but some positive signals exist.

Research suggests Bacopa's modulation of dopamine and acetylcholine systems may support attention and focus. Effects require 8-12 weeks of consistent use for measurable improvement.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dbacopa\u002Dmonnieri\u0026condition\u003Dattention\u002Dfocus'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

The Bottom Line

Research suggests Bacopa's modulation of dopamine and acetylcholine systems may support attention and focus. Effects require 8-12 weeks of consistent use for measurable improvement.

Key Study Findings

Systematic Review
Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of …
Dose: None vs: Placebo or methylphenidate Outcome: ADHD symptom severity (inattention, hyperactivity) Effect: None None

Population: ADHD patients (systematic review of supplements)

Systematic Review n=1861
The effect of plant active substances on cognitive function in healthy older adults: a systematic …
Dose: None vs: Placebo or no intervention Outcome: Cognitive function (learning, memory, executive) Effect: Raisin SUCRA 95.1%; tart cherry 89.5% for memory None

Population: Healthy older adults

Other
Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma.
Dose: Bacopa monnieri (Brahmi) vs: None Outcome: Immunomodulatory effects in breast cancer Effect: None None

Population: Retracted publication - invasive ductal carcinoma

Other 72 weeks
Online Promotion of "Brain Health" Supplements.
Dose: None vs: None Outcome: None Effect: None None

Population: None

Review
The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.
Dose: None vs: None Outcome: None Effect: None None

Population: None

Other
Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6.
Dose: None vs: None Outcome: None Effect: None None

Population: None

Key Statistics

8

Studies

600

Participants

Positive

C

Grade

Referenced Papers

The Senior care … 2021 2 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:
300-600 mg/day standardized to 50% bacosides
memorysupport:
300 mg/day for minimum 8-12 weeks

Upper limit: Not established; well-tolerated up to 600 mg/day in trials

Dosages Studied in Research

Dosage Duration Effect N
None -- Mixed --
None -- Positive 1861
Bacopa monnieri (Brahmi) -- Positive --
None 72 weeks Positive --
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Positive --

Best taken: With meals; effects require 8-12 weeks of consistent use

Safety & Side Effects

Reported Side Effects

  • Gastrointestinal discomfort (nausea, cramping, diarrhea)
  • Dry mouth
  • Fatigue in some individuals
  • Mild sedation at higher doses

Known Interactions

  • Thyroid medications (may increase thyroid hormone levels)
  • Anticholinergic drugs (opposes cholinergic enhancement)
  • Sedative medications (additive CNS depression)
  • Calcium channel blockers (may enhance blood pressure lowering)

Tolerable upper intake: Not established; well-tolerated up to 600 mg/day in trials

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Bacopa monnieri help with Attention & Focus Difficulties?
Based on 8 studies with 600 participants, there is limited but promising evidence that Bacopa monnieri may support Attention & Focus Difficulties management. Our evidence grade is C (Some Evidence).
How much Bacopa monnieri should I take for Attention & Focus Difficulties?
Studies have used various dosages. A commonly studied range is 300-600 mg/day standardized to 50% bacosides. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bacopa monnieri?
Reported side effects may include Gastrointestinal discomfort (nausea, cramping, diarrhea), Dry mouth, Fatigue in some individuals, Mild sedation at higher doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bacopa monnieri and Attention & Focus Difficulties?
We rate the evidence as Grade C (Some Evidence). This rating is based on 8 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.

References

  1. [1] Shatha Al Shahab et al.. Nutrients. 2025. Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review. doi:10.3390/nu17091482 PubMed
  2. [2] Xueyan Feng et al.. Front Pharmacol. 2025. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of … doi:10.3389/fphar.2025.1672171 PubMed
  3. [3] Sohini Roy et al.. Med Oncol. 2024. Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma. doi:10.1007/s12032-024-02365-x PubMed
  4. [4] John E Lewis et al.. J Clin Transl Res. 2021. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. PubMed
  5. [5] Brittany R Block et al.. Sr Care Pharm. 2021. Online Promotion of "Brain Health" Supplements. doi:10.4140/TCP.n.2021.489 PubMed
  6. [6] Andrea Brioschi Guevara et al.. Alzheimers Res Ther. 2021. Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6. doi:10.1186/s13195-021-00844-1 PubMed
  7. [7] Michelle D Nemetchek et al.. J Ethnopharmacol. 2017. The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain. doi:10.1016/j.jep.2016.07.073 PubMed
  8. [8] Grace M McPhee et al.. Med Hypotheses. 2016. Cognitive training and Bacopa monnieri: Evidence for a combined intervention to alleviate age associated cognitive decline. doi:10.1016/j.mehy.2016.09.002 PubMed
  9. [9] Ananya Sadhu et al.. Clin Drug Investig. 2014. Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product. doi:10.1007/s40261-014-0235-9 PubMed
  10. [10] P M Kidd. Altern Med Rev. 1999. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. PubMed

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.